Abstract
The concept to treat disease by the introduction of genes into affected human cells has become known as human somatic gene therapy. Several viral and non-viral vector systems are currently used in this context to transfer genes into human cells in vitro and in vivo. The ideal gene therapy vector, in particular for the treatment of inherited genetic disease, should enable the safe transfer of a gene construct to the affected cells and mediate efficient, physiologically regulated and permanent expression of the therapeutic gene. Unfortunately, none of the vector systems currently in use for gene therapy fulfils all these expectations although all of them carry some of the desirable features, but also certain disadvantages. Vims based vectors are designed to use the natural viral mechanisms to transfer genes and express them in target cells and at the same time to eliminate as far as possible negative viral features such as replication, immunogenicity and toxicity. In contrast non-viral vector systems try to use combinations of synthetic and natural molecules to mimic certain advantageous characteristics of the viral system while avoiding their negative features. The main factors influencing permanent and efficient expression of the introduced transgene sequences include the vector preparation, the routes of vector application, cell entry and the intracellular fate of the constructs, their expression and the activity and stability of the expressed protein in the target cells as well as the reactions of the host organism to the vector and transgene product.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P.,. Ringold, G. M., Danielson, M. (1987). Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Pro. Natl. Acad. Sci. USA 84, 7413 – 7417.
Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y. J., Border, R., Ramsey, P., Martin, M., Felgner, P. L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J.Biol. Chem 269, 2550 – 2561.
Gershon, H., Ghirlando, R., Guttman, S. B., Minsky, A. (1993). Mode of formation and structual features of DNA-cationic liposome complexes used for transfection. Biochemistry 32, 7143 – 7151.
Sternberg, B., Sorgi, F. L., Huang, L. (1994). New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS-L. 356, 361 – 366.
Lamb, B. T., Sisoda, S.S., Lawler, A. M., Slunt, H.H., Kitt, C. A., Kearnes, W. G., Pearson, P. L., Price, D. L., Gearthart, J. D. (1993). Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet. 5, 22 – 29.
Gao, X., Huang, L. (1991). A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res Commun. 179, 280 – 285.
Stewart, M. J., Plautz, G. E., Del Buono, L., Yang, Z. Y., Xu, L., Gao, X., Huang, L., Nabel, E. G., Nabel, G. J. (1992). Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice. Human. Gene Ther. 3, 268 – 275.
Nabel, E.G., Gordon, D., Yang, Z.-Y., Ling, X., San, H., Plautz, G. E., Wu, B.-Y., Gao, X., Huang, L., Nabel, G. J. (1992). Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum. Gene Ther. 3, 649 – 656.
Miller, A. D. (1992). Human gene therapy comes of age. Nature 357, 455 - 460.
Nabel, G. J., Chang, A., Nabel, E. G., Plautz, G., Fox, B. A., Huang, L., Shu, S. (1992). Clinical protocol: Immunotherapy of malignancy by in vivo gene transfer into tumors. Hum. Gene Ther. 3, 399 – 410.
Nabel, G. J., Nabel, E. G., Yang, Z.-Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., Chang, A. E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biological activity and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11207 – 11311.
Caplen, N. J., Alton, E. W. F. W., Middleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S., Jeffrey, P. K., Hodson, M. E., Coutelle, C., Huang, L., Porteous, D. J., Williamson, R., Geddes, D. M. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Medicine 1, 39 – 46.
Bear, C. E., Li, C., Kartner, N., Bridges, R. J., Jensen, T. J., Ramjeesingh, M., Riordan, J., R. (1992). Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68, 809 – 818.
Caplen, N. J., Kinrade, E., Sorgi, F., Gao, X., Gruenert, D., Geddes, D., Coutelle, C., Huang, L., Alton, E. W. F. W., Williamson, R. (1995). hi vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Chol/DOPE. Gene Ther. 2, 603 – 613.
Alton, E. W. F. W., Hay, J. G., Munro, C., Geddes, D. M. (1987). Measurement of nasal potential difference in adult cystic fibrosis, Young’s syndrome, and bronchiectasis. Thorax 42, 815 – 817.
Alton, E. W. F. W., Hay, J. G., Munro, C., Geddes, D. M. (1987). Measurement of nasal potential difference in adult cystic fibrosis, Young’s syndrome, and bronchiectasis. Thorax 42, 815 – 817.
Smythe, E., Warren, G., (1991). The mechanism of receptor mediated endocytosis. Eur.J. Biochem. 202, 689 – 699.
Wagner, E., Cotten, M., Foisner, R., Bimstiel, M. L. (1991). Transferrin-polycation- DNA complexes: The effect of polycations on the strucure of the complex and DNA delivery to cells. Proc. Natl. Acad. Sci. USA 88, 4255 – 4259.
Cotten, M.,Wagner, E., Zatloukal, K., Phillips, S., Curiel, I). T., Bimstiel, M. L., (1992). High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc. Natl. Acad. Sci. USA 89, 6094 – 6098.
Cotten, M., Längle-Rouault, F., Kirlappos, H., Wagner, E., Mechtler, K., Zenke, M., Beug, H., Birnstiel, M. L. (1990). Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl. Acad. Sci. USA 87, 4033 – 4037.
Wagner, E., Zenke, M, Cotten, M., Beug, H., Birnstiel, M. L. (1991). Transferrin- polycation conjugates as carriers for DNA uptake into cells. Proc. Natl. Acad. Sci. USA 87, 3410 – 3414.
Zenke, M., Steinlein, P., Wagner, E., Cotten, M., Beug, H., Birnstiel, M. L. (1990). Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hemopoietic cells. Proc. Natl. Acad. Sci. USA 87, 3655 – 3659.
Wu, G. Y., Wu, C. H. (1987). Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429 – 4432.
Wu, G. Y., Wu, C. H. (1987). Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263, 14621 – 14624.
Ferkol, T., Kaetzel, C. S., Davis, P. B. (1993). Gene transfer into epithelial cells by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. 92, 2394 – 2400.
Ferkol, T., Perales, J. C., Eckman, E., Kaetzel, C. S., Hanson, R. W., Davis, P. B. (1995). Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. J. Clin. Invest. 95, 493 – 502.
Hart, S., Harbottle, R., Cooper, R., Miller, A., Williamson, R., Coutelle, C. (1995). Delivery and expression mediated by an intergrin-binding peptide. Gene Therapy 2, 552 – 554.
Kaneda, Y. Iwai, K., Uchida, T. (1989). Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243, 375 – 378.
Cristiano, R. J., Smith, L. C., Woo, S. L. C. (1993). Hepatic gene therapy: Adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc. Natl. Acad. Sci. USA 90, 2122 – 2126.
Curiel, D. T., Agarwal, S., Wagner, E., Cotten, M. (1991). Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. USA 88, 8850 – 8854.
Curiel, D. T., Wagner, E., Cotten, M., Birnstiel, M. L., Agarwal, S., Li, C.-M., Loechel, S., Hu, P.-C. (1992). High-efficiency gene transfer mediated by adenovirus coupled to DNA-polylysine complexes. Human Gene Therapy 3, 147 – 154.
Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. T., Birnstil, M. L. (1992). Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89, 6099 – 6103.
Gao, L., Wagner, E., Cotten, M., Agarwal, S., Harris, C., Romer, M, Miller, L., Hu, P.-C., Curiel, D. (1993). Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA-complexes. Hum. Gene Therapy 4. 17 – 24.
Wagner, E., Plank, C., Zatloukal, K., Cotten, M., Birnstiel, M. L. (1992). Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Towards a synthetic virus-like gene transfer vehicle. Proc. Natl. Acad. Sci. USA 89, 7934 – 7938.
Perales, J. C., Ferkol, T., Molas, M., Hanson, R. W. (1994). An evaluation of receptor mediated gene transfer using synthetic DNA-ligand complexes. Eur. J. Biochem. 226, 255 – 266.
Bowman, E. J., Siebers, A., Altendorf, K. (1988). Bafilomycins: A class of inhibitors of membrane ATPases from microorganisms, animal cells and plant cells. Proc. Natl. Acad. Sci. USA 85, 7972 – 7976.
Böttger, M., Vogel, F., Platzer, M., Kiessling, U., Grade, K., Strauss, M. (1988). Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection. Biochem. Biophys. Acta. 950, 221 – 228.
Anderson, F. W. (1994). Making clinical grade vectors. Hum. Gene Ther. 5, 925 - 926.
Caplen, N. J., Gao, X., Hayes, P., Elaswarapu, R., Fisher, G., Kinrade, E., Chakera, A., Schorr, J., Hughes, B., Dorin, J. R., Porteous, D. J., Alton, E. W. F. W., Geddes, D. M., Coutelle, C., Williamson, R., Huang, L., Gilchrist, C. (1994). Gene therapy for cystic fibrosis in humans by liposome mediated DNA transfer: regulatory process and production of resources. Gene Therapy 1, 139 – 147.
Anderson, F. W. (1994). Yes, Abbey you are right. Hum. Gene Ther. 5, 1199 – 1200.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin • Heidelberg 1997
About this chapter
Cite this chapter
Coutelle, C. (1997). Gene Therapy with Non-Viral Vector Systems. In: Müller, S., Simon, J.W., Vesting, J.W. (eds) Interdisciplinary Approaches to Gene Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60829-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-60829-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63056-2
Online ISBN: 978-3-642-60829-2
eBook Packages: Springer Book Archive